CI-FER Trademark

Trademark Overview

On Thursday, January 3, 2019, a trademark application was filed for CI-FER with the United States Patent and Trademark Office. The USPTO has given the CI-FER trademark a serial number of 88248937. The federal status of this trademark filing is REGISTERED as of Tuesday, March 10, 2020. This trademark is owned by Akeso Biomedial, Inc.. The CI-FER trademark is filed in the Chemical Products category with the following description:

Chemical additives, namely, iron-citrate complexes for use as feed additives, in topical applications, particularly, oral hygiene, skin care, contact lens solutions, and in pharmaceutical formulations
ci-fer

General Information

Serial Number88248937
Word MarkCI-FER
Filing DateThursday, January 3, 2019
Status700 - REGISTERED
Status DateTuesday, March 10, 2020
Registration Number6009074
Registration DateTuesday, March 10, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements

Goods and ServicesChemical additives, namely, iron-citrate complexes for use as feed additives, in topical applications, particularly, oral hygiene, skin care, contact lens solutions, and in pharmaceutical formulations

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, January 25, 2019
Primary Code001
First Use Anywhere DateMonday, October 7, 2019
First Use In Commerce DateMonday, October 7, 2019

Trademark Owner History

Party NameAkeso Biomedial, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameAkeso Biomedial, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803
Party NameAkeso Biomedial, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events

Event DateEvent Description
Friday, January 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Wednesday, March 27, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, April 19, 2019ASSIGNED TO LIE
Wednesday, March 27, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, March 27, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 27, 2019EXAMINER'S AMENDMENT ENTERED
Monday, April 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 15, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, February 6, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 10, 2020REGISTERED-PRINCIPAL REGISTER
Monday, May 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 15, 2020USE AMENDMENT FILED
Tuesday, February 4, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 4, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 5, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 10, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 2, 2020REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
Monday, May 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 13, 2020REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED

Related Keywords

additives care skin hygiene contact solutions formulations pharmaceutical oral lens